Trials
4 active
4 in total · 3 in the EU
What this is
- How it works
- Blocks PARP, an enzyme cancer cells use to repair their DNA, so the damaged cancer cells die.-parib: PARP inhibitors WHO name stem
- Tested for
- Metastatic Prostate Cancer (2 trials), Advanced Solid Malignancies, Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
- Main trialPhase 1/2
- “This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/progressed.”In the company’s words, NCT05417594 on ClinicalTrials.gov
- Other names
- AZD9574
Other drugs for Metastatic Prostate Cancer
- ApalutamideJohnson & Johnson (Janssen) · Phase 3
- 64Cu-SAR-bisPSMAClarity Pharmaceuticals Ltd · Phase 3
- Abiraterone acetateJohnson & Johnson (Janssen) · Phase 3
- 68Ga-PSMA-11Telix Pharmaceuticals (Innovations) Pty Limited · Phase 3
- EnzalutamidePfizer · Astellas · Phase 3
- MevrometostatPfizer · Phase 3
Coming up4
- 7 Feb 2028Phase 1/2 trial completes · ClinicalTrials.gov
- 4 Aug 2028Phase 1/2 trial completes · ClinicalTrials.gov
- 18 Jan 2029Phase 1/2 trial completes · ClinicalTrials.gov
- 25 Sep 2029Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 7 Feb 2028 | Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies | |
| Phase 1/2Recruiting | 4 Aug 2028 | Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors | |
| Phase 1/2Recruiting | 18 Jan 2029 | Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer | |
| Phase 1/2Recruiting | 25 Sep 2029 | Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026